SecBot SecBot
Insider Cluster (4 insiders) ·Filed May 28, 2026

FLGT

Fulgent Genetics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $38K total
Actionable Insight • Neutral

The insider sales are too small to be informative. Monitor for any material corporate events (earnings, guidance, M&A) that could provide context. The cross-filing amplifiers suggest this cluster would be more significant if dollar amounts were larger, but at current size, no action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
FLGT ▲ +7.22% at T+60d
NEUTRAL call +7.22% · α vs SPY +6.04% · entry $18.14 → $19.45
Entry = T+0 close
May 28, 2026
via day close
T+1d
-0.28%
call -0.28% · α -0.53%
$18.09
settled 5mo ago
T+5d
+5.57%
call +5.57% · α +8.09%
$19.15
settled 5mo ago
T+20d
+13.18%
call +13.18% · α +14.97%
$20.53
settled 4mo ago
T+60d
+7.22%
call +7.22% · α +6.04%
$19.45
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Fulgent Genetics (President/COO and CSO) made open-market sales totaling ~$38K on May 27, 2026, at ~$17.60/share. The dollar value is trivial relative to the $508M market cap (~0.007%), and the sales are likely liquidity-driven rather than signaling deterioration. The cluster is amplified by cross-filing context (multiple amplifier pairs fired), but the absolute magnitude is too small to warrant a directional call.

Key Financial Metrics

Direction
selling
Total Value
$38.0K
Insiders
4

Key Facts

  • President/COO Xie Jian sold 1,201 shares for ~$21K on May 27, 2026.
  • CSO Gao Hanlin sold 945 shares for ~$17K on May 27, 2026.
  • Total open-market sales: ~$38K, representing ~0.007% of $508M market cap.
  • CFO and CEO had tax-withholding transactions on May 26 (non-cash, no economic signal).
  • No open-market purchases in the cluster.
  • Cross-filing amplifiers fired (cluster-insider-trades + multiple contexts), but the dollar value is far below materiality thresholds.

Financial Impact

~$38K in open-market sales, ~0.007% of market cap — trivial.

insider selling volume

Risk Factors

  • Insider sales could accelerate if negative news emerges, but current pattern is routine.
  • No purchases to offset the selling signal — though sales are de minimis.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-FLGT-1780003430934
3 reports for FLGT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FLGT — sortable, filterable
TypeNow
May 28, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.14 $19.45▲ +7.22%▲ +6.04%$20.22 (+11.47%)
May 28, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.14 $19.45▲ +7.22%▲ +6.04%$20.22 (+11.47%)
May 21, 2026
22w ago
8-K
BULLISH ★ 7/10
$17.11 $18.57▲ +8.53%▲ +5.34%$20.22 (+18.18%)
Showing 3 of 3

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026